RU2019111101A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2019111101A3 RU2019111101A3 RU2019111101A RU2019111101A RU2019111101A3 RU 2019111101 A3 RU2019111101 A3 RU 2019111101A3 RU 2019111101 A RU2019111101 A RU 2019111101A RU 2019111101 A RU2019111101 A RU 2019111101A RU 2019111101 A3 RU2019111101 A3 RU 2019111101A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0042—Nitrogen only
- C07J71/0047—Nitrogen only at position 2(3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662408314P | 2016-10-14 | 2016-10-14 | |
| US62/408,314 | 2016-10-14 | ||
| PCT/US2017/056447 WO2018071736A1 (en) | 2016-10-14 | 2017-10-13 | Structures and mechanism for the design of highly potent glucocorticoids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2019111101A RU2019111101A (ru) | 2020-11-16 |
| RU2019111101A3 true RU2019111101A3 (enExample) | 2020-11-27 |
Family
ID=61906432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019111101A RU2019111101A (ru) | 2016-10-14 | 2017-10-13 | Структуры и механизм для дизайна высокоактивных глюкокортикоидов |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10954265B2 (enExample) |
| EP (1) | EP3525870B1 (enExample) |
| JP (2) | JP7146750B2 (enExample) |
| KR (1) | KR102497070B1 (enExample) |
| CN (1) | CN110382033B (enExample) |
| ES (1) | ES2945983T3 (enExample) |
| MA (1) | MA46539A (enExample) |
| PH (1) | PH12019500801A1 (enExample) |
| RU (1) | RU2019111101A (enExample) |
| SG (1) | SG11201903209TA (enExample) |
| WO (1) | WO2018071736A1 (enExample) |
| ZA (1) | ZA201902595B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025119398A1 (zh) * | 2023-12-08 | 2025-06-12 | 浙江柏拉阿图医药科技有限公司 | 高效力糖皮质激素多晶型及其制备方法和用途 |
| WO2025157225A1 (zh) * | 2024-01-24 | 2025-07-31 | 浙江柏拉阿图医药科技有限公司 | 一种高效力糖皮质激素化合物及其制备和用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK66202C (da) | 1945-03-03 | 1948-01-12 | Danske Securitas As | Kodekontakt til elektriske Alarmanlæg. |
| DK71662C (da) | 1946-09-05 | 1950-11-06 | Ingenioer Frank Broadbent | Tørrecentrifuge. |
| US4049813A (en) | 1976-07-15 | 1977-09-20 | Sandoz, Inc. | Substituted isoxazolo pyridinones |
| US5837698A (en) * | 1996-05-02 | 1998-11-17 | G. D. Searle & Co. | Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs |
| JPWO2002102807A1 (ja) | 2001-06-14 | 2004-09-30 | 萬有製薬株式会社 | 新規イソキサゾロピリドン誘導体及びその用途 |
| GB0119911D0 (en) | 2001-08-15 | 2001-10-10 | Novartis Ag | Organic Compounds |
| CN1901863A (zh) * | 2003-11-13 | 2007-01-24 | 康宾纳特克斯公司 | 治疗炎性疾病的方法和药物 |
| CN101300265A (zh) * | 2005-09-02 | 2008-11-05 | 尼科克斯公司 | 糖皮质激素硝酰氧基衍生物 |
| CN1813768A (zh) * | 2005-11-18 | 2006-08-09 | 成都力思特制药股份有限公司 | 治疗呼吸系统疾病的药用组合物及其在制药中的应用 |
| EP2207788A1 (en) | 2007-10-04 | 2010-07-21 | AstraZeneca AB | Steroidal [3, 2-c]pyrazole compounds, with glucocorticoid activity |
| CA2707618A1 (en) * | 2007-12-20 | 2009-07-02 | Astrazeneca Ab | Steroid derivatives acting as glucocorticosteroid receptor agonists |
| WO2010083218A1 (en) | 2009-01-13 | 2010-07-22 | Van Andel Research Institute | Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids |
| UY32520A (es) | 2009-04-03 | 2010-10-29 | Astrazeneca Ab | Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides |
| UY32523A (es) | 2009-04-03 | 2010-10-29 | Astrazeneca Ab | Compuestos que tienen actividad agonista del receptor de glucocorticosteroides |
| UY32525A (es) | 2009-04-03 | 2010-10-29 | Astrazeneca Ab | Compuestos que tienen actividad agonista del receptor de glucocorticosteroides |
| EP2443134A2 (en) | 2009-06-16 | 2012-04-25 | Schering Corporation | NOVEL [3,2-c]HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF |
| AU2014324961A1 (en) * | 2013-09-25 | 2016-04-14 | Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Highly potent glucocorticoids |
| TWI695831B (zh) * | 2014-09-13 | 2020-06-11 | 香港商南北兄弟藥業投資有限公司 | Ｃｒｔｈ２拮抗劑化合物及其用途 |
-
2017
- 2017-10-13 WO PCT/US2017/056447 patent/WO2018071736A1/en not_active Ceased
- 2017-10-13 RU RU2019111101A patent/RU2019111101A/ru unknown
- 2017-10-13 JP JP2019520039A patent/JP7146750B2/ja active Active
- 2017-10-13 CN CN201780076320.7A patent/CN110382033B/zh active Active
- 2017-10-13 MA MA046539A patent/MA46539A/fr unknown
- 2017-10-13 US US16/341,275 patent/US10954265B2/en active Active
- 2017-10-13 KR KR1020197013291A patent/KR102497070B1/ko active Active
- 2017-10-13 EP EP17860202.5A patent/EP3525870B1/en active Active
- 2017-10-13 ES ES17860202T patent/ES2945983T3/es active Active
- 2017-10-13 SG SG11201903209TA patent/SG11201903209TA/en unknown
-
2019
- 2019-04-12 PH PH12019500801A patent/PH12019500801A1/en unknown
- 2019-04-24 ZA ZA2019/02595A patent/ZA201902595B/en unknown
-
2022
- 2022-07-14 JP JP2022113322A patent/JP2022132464A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US10954265B2 (en) | 2021-03-23 |
| WO2018071736A9 (en) | 2019-05-23 |
| EP3525870A1 (en) | 2019-08-21 |
| JP2019532071A (ja) | 2019-11-07 |
| ES2945983T3 (es) | 2023-07-11 |
| PH12019500801A1 (en) | 2019-11-11 |
| RU2019111101A (ru) | 2020-11-16 |
| EP3525870A4 (en) | 2020-04-29 |
| WO2018071736A1 (en) | 2018-04-19 |
| CN110382033B (zh) | 2022-04-15 |
| JP7146750B2 (ja) | 2022-10-04 |
| ZA201902595B (en) | 2021-04-28 |
| US20190263853A1 (en) | 2019-08-29 |
| EP3525870B1 (en) | 2023-05-10 |
| JP2022132464A (ja) | 2022-09-08 |
| KR20190068577A (ko) | 2019-06-18 |
| KR102497070B1 (ko) | 2023-02-06 |
| MA46539A (fr) | 2019-08-21 |
| SG11201903209TA (en) | 2019-05-30 |
| CN110382033A (zh) | 2019-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112019009201A2 (enExample) | ||
| BR112019002665A2 (enExample) | ||
| BR112018004986A2 (enExample) | ||
| BR112019008105A2 (enExample) | ||
| BR112019001429A2 (enExample) | ||
| BR112019008318A2 (enExample) | ||
| BR112019000402A2 (enExample) | ||
| BR112019008315A2 (enExample) | ||
| BR212018070320U2 (enExample) | ||
| BR112019008501B1 (pt) | Método realizado por um equipamento de usuário, método realizado por um nó de rede, equipamento de usuário, nó de rede, e, meios de armazenamento legíveis por computador | |
| BR112019003116B1 (pt) | Configuração de símbolo de rajada comum de uplink | |
| BR112019002215B1 (pt) | Seleção de nível de melhoramento de cobertura baseada em classe de potência | |
| BR112018075550B1 (pt) | Método para reparo de arquivo de intervalo de bytes, dispositivo de computação e memória | |
| BR112018076493B1 (pt) | Sistemas e métodos para detecção de posição de feixe de luz | |
| BR112018073794B1 (pt) | Partícula, método de geração da partícula, vacina ou composição farmacêutica | |
| BR112018073322B1 (pt) | Método para comunicação sem fio realizado por um equipamento de usuário (ue), método para comunicação sem fio realizado por uma estação base (bs), aparelho para comunicações sem fio, e, memória legível por computador | |
| BR112018072681B1 (pt) | Anticorpos anti-il-1r3 humanizados, fragmento ou derivado do mesmo, seu uso e composição farmacêutica | |
| BR122026002520A2 (pt) | Célula, conjunto de vetores para expressar uma proteína de ligação a antígeno biespecífica em uma célula, conjunto de vetores, sistema, método, e, método para produção de uma proteína de ligação a antígeno | |
| BR112019006736A2 (enExample) | ||
| CN303536221S (enExample) | ||
| CN303549873S (enExample) | ||
| CN303536207S (enExample) | ||
| CN303561027S (enExample) | ||
| CN303536593S (enExample) | ||
| CN303536110S (enExample) |